跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Guaifenesin, Papaverine Hydrochloride and Codeine Phosphate Tablets
Approved
化学药品
Guaifenesin, Papaverine Hydrochloride and Codeine Phosphate Tablets
澳美製藥廠有限公司
🇨🇳 National Medical Products Administration
Approval Date
Sep 18, 2021
Approval ID
8DqcEKZtWKh
Company
澳美製藥廠有限公司
Type
化学药品
Approval Details
Approval Id
8DqcEKZtWKh
Approval Number
国药准字HC20160034
Generic Name
愈创罂粟待因片
Generic Name En
Guaifenesin, Papaverine Hydrochloride and Codeine Phosphate Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含磷酸可待因(按C18H21NO3.H3PO4计)6mg、盐酸罂粟碱(按C20H21NO4.HCl计)30mg和愈创木酚甘油醚(按C10H14O4计)100mg
Reg Date
2021-09-18
Expired Date
2026-09-17
Company Name
澳美製藥廠有限公司
Production Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Production Company Address
香港新界元朗工业村宏富街1号澳美制药中心
Company Detail Path
/organization/ao-mei-zhi-yao-chang-you-xian-gong-si
Production Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 18, 2021
Approval ID
8DqcEKZtWKh
Type
化学药品
Back to NMPA Approvals
愈创罂粟待因片 - NMPA Drug Approval Details